The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Oil Prices Rebound as Iran Denies U.S. Talks Amid Gulf War Supply Fears
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
Currency Markets Show Caution Amid U.S.-Iran Negotiations
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit 



